FG 020326

Known as: FG-020326, FG020326 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2012
01220042012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Apoptotic resistance is the main obstacle for treating cancer patients with chemotherapeutic drugs. Multidrug resistance (MDR) is… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
The effectiveness of chemotherapeutic treatment is usually limited by the overexpression of adenosine triphosphate binding… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2008
2008
To overcome multidrug resistance (MDR) existing in tumor chemotherapy, polymeric micelles encoded with folic acid on the micelle… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
2007
2007
AbstractAim:FG020326, a novel imidazole derivative, is a potent multidrug-resistance (MDR) modulator in vitro and in vivo… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2004
2004
The overexpression of P-glycoprotein (P-gp) by tumor cells results in multidrug resistance (MDR) to structurally unrelated… (More)
Is this relevant?
2004
2004
BACKGROUND & OBJECTIVE Multidrug resistance (MDR) is often characterized by over-expression of P-glycoprotein (P-gp) as drug… (More)
Is this relevant?